Radiotherapy

Frontiers of Radiation Therapy and Oncology

Volumn 42, Issue , 2010, Pages 164-172

  Adamietz, Irenäus A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COUGHING; EXTERNAL BEAM RADIOTHERAPY; HEMOPTYSIS; HUMAN; LUNG NON SMALL CELL CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SYMPTOM; THORAX PAIN; TREATMENT PLANNING;

BRACHYTHERAPY; HUMANS; LUNG NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 77949343122     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000262472     Document Type: Review

References (35)

1. Chahinian A, Israel L: Rates and patterns of growth of lung cancer; in Israel L, Chahinian AP (eds): Lung Cancer: Natural History, Prognosis and Therapy. New York, Academic Press, 1976, pp 63-79.
2. Chang JY, Bradley JD, Govindan R, Komaki R: Lung; in Halperin EC, Perez CA, Brady LW (eds): Perez and Brady's Principles and Practice of Radiation Oncology, ed 5. Philadelphia, Wolters Kluwer/ Lippincott Wiliams & Wilkins, 2008, pp 1076-1080.
3. Martins SJ, Pereira JR: Clinical factors and prognosis in non-small cell lung cancer. Am J Clin Oncol 1999;22:453-457.
4. Sirzen F, Kjellen E, Sorenson S, Cavallin-Stahl E: A systematic overview of radiation therapy effects in non-small cell lung cancer. Acta Oncol 2003; 42:493-515.
5. Hoegler D: Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer 1997; 21:129-183.
6. Graham PH, Gebski VJ, Langlands AO: Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1995;31:261-266.
7. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360.
8. Fletcher GH: Clinical dose response curves of human malignant epithelial tumours. Br J Radiol 1973;46:151.
9. Fairchild A, Harris K, Barnes E, et al: Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 2008;26:4001-4411
10. Hennequin C, Bleichner O, Tredaniel J, et al: Longterm results of endobronchial brachytherapy: a curative treatment? Int J Radiat Oncol Biol Phys 2007;67:425-430.
11. Zorlu AF, Selek U, Emri S, Gurkaynak M, Akyol FH: Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma. Yonsei Med J 2008;49:620-624.
12. Gressen EL, Werner-Wasik M, Cohn J, Topham A, Curran WJ Jr: Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer. Am J Clin Oncol 2000;23: 160-163.
13. Kramer GW, Gans S, Ullmann E, van Meerbeeck JP, Legrand CC, Leer JW: Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment? Int J Radiat Oncol Biol Phys 2004;58: 1388-1393.
14. Cross CK, Berman S, Buswell L, Johnson B, Baldini EH: Prospective study of palliative hypofractionated radiotherapy (8.5 Gy × 2) for patients with symptomatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;58:1098-1105.
15. Timothy AR, Girling DJ, Saunders MI, Macbeth F, Hoskin PJ: Radiotherapy for inoperable lung cancer. Clin Oncol (R Coll Radiol) 2001;13:86-87.
16. Okawara G, Mackay JA, Evans WK, Ung YC: Management of unresected stage III non-small cell lung cancer: a systematic review. J Thorac Oncol 2006;1: 377-393.
17. Adamietz IA: Palliative Radiotherapie; in Bamberg M, Molls M, Sack H (eds): Radioonkologie. Munchen, Zuckschwerdt, 2004, pp 1117-1155.
18. Rades D, Bohlen G, Dunst J, et al: Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol 2008;184:30-35.
19. Rades D, Kueter JD, Hornung D, et al: Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases. Strahlenther Onkol 2008;184:655-662.
20. Rades D, Rudat V, Veninga T, et al: A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2008;72:905-908.
21. Rades D, Veninga T, Stalpers LJ, et al: Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. J Clin Oncol 2007;25:50-56.
22. Wudel LJ Jr, Nesbitt JC: Superior vena cava syndrome. Curr Treat Options Oncol 2001;2:77-91.
23. Simpson JR, Francis ME, Perez-Tamayo R, et al: Palliative radiotherapy for inoperable carcinoma of the lung: Final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 1985;11: 751-758.
24. Teo P, Tai TH, Choy D, et al: Randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1988;14:867-871.
25. Medical Research Council Lung Cancer Working Party: Inoperable non-small-cell lung cancer: A Medical Research Council randomized trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 1991;63:265-270.
26. Medical Research Council Lung Cancer Working Party: A Medical Research Council randomized trial of palliative radiotherapy with two fractions of a single fraction in patients with inoperable non-small-cell lung cancer and poor performance status. Br J Cancer 1992;65:934-941.
27. Abratt RP, Shepherd LJ, Mameena Salton DG: Palliative radiation for stage 3 non-small-cell lung cancer: A prospective study of two moderately high dose regimens. Lung Cancer 1995;13:137-143.
28. Medical Research Council Lung Cancer Working Party: Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small-cell lung cancer and good performance status. Clin Oncol (R Coll Radiol) 1996;8:167-175.
29. Rees GJ, Devrell CE, Barley VL, et al: Palliative radiotherapy for lung cancer: Two versus five fractions. Clin Oncol (R Coll Radiol) 1997;9:90-95.
30. Nestle U, Nieder C, Walter K, et al: A palliative accelerated irradiation regimen for advanced nonsmall-cell lung cancer vs conventionally fractionated 60Gy: Results of a randomized equivalence study. Int J Radiat Oncol Biol Phys 2000;48:95-103.
31. Bezjak A, Dixon P, Brundage M, et al: Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC. 15). Int J Radiat Oncol Biol Phys 2002;54:719-728.
32. Sundstrom S, Bremnes R, Aasebo U, et al: Hypofractionated palliative radiotherapy (17Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial. J Clin Oncol 2004;22:801-810.
33. Erridge SC, Gaze MN, Price A, et al: Symptom control and quality of life in people with lung cancer: A randomized trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 2005;17:61-67.
34. Kramer GW, Wanders SL, Noordijk EM, et al: Results of the Dutch national study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol 2005;23:2962-2970.
35. Senkus-Konefka E, Dziadziuszko, Bednaruk-Mlynski E, et al: A prospective, randomized study to compare two palliative radiotherapy schedules for non-small-cell lung cancer. Br J Cancer 2005;92: 1038-1045.